Cristina
Almenglo Buzón
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (4)
2024
-
Edoxaban treatment in a post-infarction experimental model
European Journal of Pharmacology, Vol. 962
-
Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation
Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23
2022
-
Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin
Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 16, pp. 4416-4427
-
The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation
International Journal of Molecular Sciences, Vol. 23, Núm. 19